San Francisco

ARUP's New Institute for Research and Innovation in Diagnostic and Precision Medicine™ Will Forge the Future of Laboratory Medicine

Retrieved on: 
Friday, September 29, 2023
San Francisco, Laboratory, University, Clinical trial, CSO, ARUP Laboratories, University of California, San Francisco, COVID-19, Pathology, Stanford University, Research, Attention, History, SALT, Doctor of Philosophy, Translation, Harvard Medical School, ARUP, HERO, Stanford University School of Medicine, Leukemia, Tron Lightcycle Power Run, Patient, Machine learning, Physician, Lymphoma, Flow cytometry, Artificial intelligence, New institutional economics, Diagnosis, Growth, R, FDA, Medical device, Pharmaceutical industry, Medical imaging, MD

SALT LAKE CITY, Sept. 29, 2023 /PRNewswire/ -- ARUP Laboratories today announced the formation of the new ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ (R&I Institute).

Key Points: 
  • SALT LAKE CITY, Sept. 29, 2023 /PRNewswire/ -- ARUP Laboratories today announced the formation of the new ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ (R&I Institute).
  • The institute will improve the lives of patients by advancing groundbreaking diagnostic and prognostic technologies and innovative tests.
  • Now, with a broad vision as CSO and president of the Innovation Business Unit, her attention has turned to the R&I Institute.
  • "We've seen the need and the opportunity, and now we're here to fearlessly seek out the future of laboratory medicine."

Regel Therapeutics Awarded $1 Million from HS Chau Women in Enterprising Science Program at the Innovative Genomics Institute to Continue Developing Its Gene Modulation Technology

Retrieved on: 
Friday, September 29, 2023
San Francisco, Nobel Prize, CRISPR, Therapy, Nobel Prize in Chemistry, Biotechnology, University of California, San Francisco, Woman, Research, Gene expression, DSM-IV codes, HS, IGI, UC, Nobel, Entrepreneurship, Pharmaceutical industry, Medical device, Eduard August von Regel, Chemistry

The HS Chau WIES Program at the IGI is committed to addressing gender inequity in biotechnology and supporting entrepreneurs to develop innovative solutions for some of the world's greatest health problems.

Key Points: 
  • The HS Chau WIES Program at the IGI is committed to addressing gender inequity in biotechnology and supporting entrepreneurs to develop innovative solutions for some of the world's greatest health problems.
  • The IGI is working to advance revolutionary biotechnology that translates scientific breakthroughs into real-world solutions that are accessible and affordable.
  • With the generous philanthropic support of Solina Chau Hoi Shuen of Horizons Ventures, the IGI launched the WIES program to support and guide entrepreneurs who align with its mission.
  • Scientists selected for the program receive access to world-class resources to further their research using technologies such as CRISPR.

UCSF QBI, University College London, and Mount Sinai Identify Shared Molecular Mechanisms Across SARS-CoV-2 Variants that Allow Virus to Thrive Despite Vaccination

Retrieved on: 
Thursday, September 21, 2023
Vaccine, San Francisco, Infection, University College London, UCL, Cell Host & Microbe, Omicron, Senior, Life, HIV, Icahn School of Medicine at Mount Sinai, University, SARS-CoV-2, System, ORF6, COVID-19, Survival, University of California, San Francisco, Emerging Pathogens Institute, Viral, Research, Mount Sinai, Cell, Doctor of Philosophy, Delta, Assistant, Global Health, QBI, Genetics, Pandemic, G.H. Raisoni Department of Microbiology and Biotechnology, Quantitative Biosciences Institute, UC, UCSF, Laboratory, Pathology, SAN, CELL, School, Immune system, Gladstone Institutes, UCLA, Health, Adolfo, Virus, Pharmacy, Microbiology, Alpha

SAN FRANCISCO and LONDON, Sept. 21, 2023 (GLOBE NEWSWIRE) -- In a study published online in CELL today, scientists at UCSF QBI, University College London and the Icahn School of Medicine at Mount Sinai reported breakthrough findings on convergent evolutionary mechanisms shared by COVID-19 variants, allowing them to overcome both adaptive and innate immune system barriers. In the paper titled, SARS-CoV-2 Variants Evolve Convergent Strategies to Remodel the Host Response, scientists carried out an unprecedented, systematic comparative study using the most infectious COVID-19 variants, namely Alpha, Beta, Gamma, Delta and Omicron to identify specific viral mutations responsible for hijacking a common host pathway, thereby leading to increased transmissibility, infectivity and survival. Specifically, they discovered a convergence in potent suppression of interferon-stimulated genes through several viral proteins, including Orf6 and Orf9b, which serve as innate immune antagonist proteins capable of blocking innate host immune response.

Key Points: 
  • The award, which included a $200,000 prize, is intended to provide support for his vision for progress against pandemic threats.
  • “Unfortunately, we continue to see new mutations and strains of SARS-CoV-2 despite innovations in new vaccines,” said Dr. Krogan, who founded the QBI Coronavirus Research Group (QCRG).
  • This finding is consistent with our investigation of early SARS-CoV-2 variants where certain viral proteins were highly expressed in infected cells which helped the virus infect our cells.
  • Their analysis pinpointed cellular pathways that are similarly modulated across variants during infection and represent putative targets for pan-coronavirus antivirals.

Cryo-electron Microscopy Market Size Envisaged to Reach USD 3.41 Billion By 2032, at a CAGR of 11.4%: Polaris Market Research

Retrieved on: 
Friday, September 22, 2023
San Francisco, Electron, University, Prevalence, Biotechnology, University of California, San Francisco, Microscopy, Cancer, Software, Research, Thermo Fisher Scientific, Government, Alzheimer's disease, SEM, Detail, Acquisition, Investment, UCSF, Biophysics, Drug discovery, Comprehension, Protein engineering, Conditional sentence, Cryo, Therapy, Nanotechnology, Geography, Online shopping, Microscope, Pharmaceutical industry, Video game, Renewable energy, Cassette tape, Cryogenic electron microscopy, Application

Numerous academic and research institute has surged the adoption of highly technological Cryo-electron microscopes, which is enhancing the Cryo-electron microscopy market growth.

Key Points: 
  • Numerous academic and research institute has surged the adoption of highly technological Cryo-electron microscopes, which is enhancing the Cryo-electron microscopy market growth.
  • By technology Cryo-electron microscopy market segmentation, scanning electron microscopy category accounts for a significant revenue share.
  • Moreover, increasing investments in R&D by government and private firms are boosting the Cryo-electron microscopy market growth in North America.
  • Polaris Market Research has segmented the Cryo-electron Microscopy market report based on product, technology, application, and region:

Wescom Credit Union Expands Field of Membership to Serve More Californians

Retrieved on: 
Tuesday, September 19, 2023
Banking, Personal Finance, Professional Services, Finance, San Francisco, Pasta â Paolina, Silicon, Central Coast, Growth, UCLA, Credit union, News, Harbor, Wescom Credit Union

Wescom Credit Union , on the heels of its Central Coast Federal Credit Union (CCFCU) merger news , has today announced that in addition to the eight Southern California Counties it currently serves, the Credit Union will now serve an additional thirteen counties in California.

Key Points: 
  • Wescom Credit Union , on the heels of its Central Coast Federal Credit Union (CCFCU) merger news , has today announced that in addition to the eight Southern California Counties it currently serves, the Credit Union will now serve an additional thirteen counties in California.
  • Wescom, one of the largest community credit unions in the entire state, and a fixture in Southern California since 1934, has long served communities throughout Los Angeles, Orange, Riverside, San Bernardino, San Diego, Imperial, Ventura and Santa Barbara counties, including the UCLA community.
  • “By expanding our field of membership in an adjacent market, we are able to serve more Californians and make a positive impact in additional communities,” stated Darren Williams, President and CEO of Wescom.
  • This means that Wescom membership is now available to close to 27.7 million Californians, representing more than 70 percent of the California population.

Forty Creek Launches Cherrywood Reserve, Made and Inspired by Local Fruits from the Niagara Region

Retrieved on: 
Tuesday, September 19, 2023
San Francisco, Music, Vanilla, Wood, Visitor, Gold, Niagara Region, San Francisco World Spirits Competition, Ageing, Master blender, Forty Creek, Character, Beer, Liquor

Cherrywood Reserve pays homage to the Niagara Region by crafting an exquisite whisky steeped in cherry wood from one of Ontario's most treasured fruit belts, bringing out a wonderfully unexpected character and flavour.

Key Points: 
  • Cherrywood Reserve pays homage to the Niagara Region by crafting an exquisite whisky steeped in cherry wood from one of Ontario's most treasured fruit belts, bringing out a wonderfully unexpected character and flavour.
  • Cherrywood Reserve is a 5-year-old pot distilled whisky made with malted barley, rye and corn, and a hint of aged brandy.
  • "It is uniquely inspired by the Niagara Region, Canada's treasure and the source of over 90% of Ontario's tender fruit crop, including sweet and sour cherries."
  • Forty Creek Cherrywood Reserve is now available for sale in select provinces across Canada and on fortycreekwhisky.com , retailing for $89.95.

Menlo Equities and Beacon Capital Partners Break Ground on 240,000 SF Life Science Building in San Carlos, CA

Retrieved on: 
Thursday, September 14, 2023
Science, Commercial Building & Real Estate, Other Science, Construction & Property, Finance, Professional Services, REIT, Other Construction & Property, San Francisco, Heart, Cushman, Cushman & Wakefield, Multimedia, CBRE, Wind, HQ, Walking, Portal, San Francisco Bay, San Carlos station, Beacon Capital Partners, Growth, Stock, Ecosystem, Tunnel, CalTrain

Menlo Equities, a vertically-integrated commercial real estate investment and development firm, and Beacon Capital Partners, a leading real estate developer, owner, and manager of life science and office properties, are pleased to announce the groundbreaking of Portal 405, a 240,000 square foot life science building in the heart of the burgeoning life science market of San Carlos, CA.

Key Points: 
  • Menlo Equities, a vertically-integrated commercial real estate investment and development firm, and Beacon Capital Partners, a leading real estate developer, owner, and manager of life science and office properties, are pleased to announce the groundbreaking of Portal 405, a 240,000 square foot life science building in the heart of the burgeoning life science market of San Carlos, CA.
  • View the full release here: https://www.businesswire.com/news/home/20230914459799/en/
    Portal 405 will be a six-story building conveniently located within walking distance to the San Carlos Caltrain Station and the extensive amenities of Downtown San Carlos.
  • “San Carlos is an important and prominent life science hub, and we look forward to complementing the existing ecosystem with a new state-of-the-art facility that will attract forward-thinking life science users,” said Rick Holmstrom, Managing Partner of Menlo Equities.
  • “We believe in the strength of this location and the continued growth of the life science sector here,” said Steve Purpura, President of Life Sciences at Beacon Capital Partners.

Illva Saronno Holding S.p.A. Announces Majority Stake Purchase of Sagamore Spirit

Retrieved on: 
Thursday, September 14, 2023
San Francisco, Brand, LLP, Disaronno, Commitment, Ageing, Acquisition, Headquarters, Reed Smith, San Francisco World Spirits Competition, Growth, City, KPMG, Liquor

BALTIMORE, Sept. 14, 2023 /PRNewswire-PRWeb/ -- Illva Saronno Holding S.p.A., an Italian Multinational Company with a strong strategic diversification of business and products, today announced a majority stake purchase of shares of Baltimore-based Sagamore Spirit rye whiskey brand and distillery. The deal supports the long-term growth of both companies and strengthens Illva Saronno Holding's presence in the United States, which started with Disaronno International LLC in 2014. Illva Saronno Holding is most recognizably known for Disaronno, the world's favorite Italian liqueur. The acquisition also creates the opportunity for Illva Saronno Holding S.p.A. to expand their whiskey portfolio beyond The Busker Irish Whiskey into American rye whiskey.

Key Points: 
  • Illva Saronno Holding Spa Doubles Down on Commitment to US Market, Baltimore Peninsula becomes the new Headquarters for Disaronno International LLC
    BALTIMORE, Sept. 14, 2023 /PRNewswire-PRWeb/ -- Illva Saronno Holding S.p.A. , an Italian Multinational Company with a strong strategic diversification of business and products, today announced a majority stake purchase of shares of Baltimore-based Sagamore Spirit rye whiskey brand and distillery.
  • Illva Saronno Holding is most recognizably known for Disaronno, the world's favorite Italian liqueur.
  • The acquisition also creates the opportunity for Illva Saronno Holding S.p.A. to expand their whiskey portfolio beyond The Busker Irish Whiskey into American rye whiskey.
  • Paul Hastings together with Bonelli Erede / BELEX (Milan) are serving as legal counsel and KPMG for financial due diligence services to Illva Saronno Holding S.p.A.

National Pro-Life Activist Declares Her Candidacy for the Democratic Party's Nomination for President

Retrieved on: 
Thursday, September 14, 2023
San Francisco, Joe Biden 2020 presidential campaign, White House, Born-Alive Infants Protection Act, Freedom of Access to Clinic Entrances Act, Democrat, FACE, Human, Multimedia, Government, White, Planned Parenthood, Comitas terrisae, Democratic Party, Party, Political lists, Democratic Party (United States), Birth control

Bukovinac will be mounting a primary challenge to President Biden as a pro-life Democrat, the first completely pro-life Democrat to seek the Party's Presidential nomination since Ellen McCormack in 1976.

Key Points: 
  • Bukovinac will be mounting a primary challenge to President Biden as a pro-life Democrat, the first completely pro-life Democrat to seek the Party's Presidential nomination since Ellen McCormack in 1976.
  • Terrisa is running for President to make visible the injustice of post-viability abortion, which despite the Dobbs decision, is still tragically legal in many states.
  • She is also running for President to amplify the voices of the tens of millions of pro-life Democrats who are currently neglected and ignored by the Democratic Party.
  • Terrisa has a unique pro-life platform that makes her the most pro-life candidate of either major party running for President this election cycle.

Culture Biosciences Appoints Darcy Birse as Chief Commercial Officer

Retrieved on: 
Wednesday, September 13, 2023
San Francisco, Business development, Partnership, Advisory board, Stockholm University, Biotechnology, Business, Doctor of Philosophy, CCO, Marketing, Assistant, Bachelor of Science, AAV, Globally Executable MHP, EMBO, Dalhousie University, CST, Structural biology, Cell, Biophysics, Growth, Adeno-associated virus, Culture, SVP, Management, Fine chemical, Biochemistry, Chemistry, Physics

South San Francisco, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences , a leading provider of innovative, future-forward bioprocessing solutions, is pleased to announce the appointment of Darcy Birse as the company's new Chief Commercial Officer (CCO).

Key Points: 
  • South San Francisco, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences , a leading provider of innovative, future-forward bioprocessing solutions, is pleased to announce the appointment of Darcy Birse as the company's new Chief Commercial Officer (CCO).
  • Darcy will lead the company's commercial strategy and drive growth initiatives to further strengthen Culture's position as a leader in the bioprocessing industry.
  • With a career spanning over 30 years in the life sciences sector, Darcy brings a wealth of global experience in Commercial Leadership, Marketing, Sales and Business Development to Culture Biosciences.
  • "As we continue to expand our presence in the bioprocessing market and deliver novel solutions to our clients, we are thrilled to welcome Darcy Birse to our executive team," said Will Patrick, CEO and Co-founder of Culture Biosciences.